1/1
The value of the accelerated approval pathway: Real-world outcomes associated with reducing the time between innovations - supplementary material
dataset
posted on 2024-01-23, 09:38 authored by William Wong, Stacey Kowal, Tu My To, Achal Patel, David Veenstra, Louis Garrison, Meng LiSupplementary table 1. Patient selection and attrition.
Supplementary table 2. Patient characteristics.
Supplementary table 3. Proportion of patients surviving to the AA date in real-world database and population level.
Supplementary figure
